secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001104659-23-066013
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Health shareholders approve new incentive plan and ESPP amendment; severance plan for execs
--------------------------------------------------------------------------------

- Shareholders approved the 2023 Incentive Award Plan, authorizing 8,250,000 shares for future equity grants.
- ESPP amendment increases share reserve by 3,000,000 shares, removes evergreen clause, caps contributions at 15%.
- Compensation Committee approved the Level 14 Severance Plan (effective June 1, 2023) for eligible executives.
- Severance provides 6 months base salary (non-Change of Control) or 9 months plus 75% target bonus (Change of Control).
- All nine director nominees elected; advisory vote on executive compensation passed (74.4M for vs 16.4M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/0001104659-23-066013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000110465923066013/tm2317113d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-066013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer